JJ COVID-19 vaccine under EU review over blood clo

2022-04-05
  • Detail
J&J COVID-19 vaccine under EU review over blood clots - Today News Post News Post || Euro News:

Europe’s drug regulator said it is reviewing reports of rare blood clots in four people who received Johnson & Johnson’s COVID-19 vaccine and has expanded its probe into AstraZeneca’s shot to include reports of a bleeding conditionWe have already offered COVID-19 support to Ontario.

Of the four serious cases of clotting and low platelets, three occurred in the United States during the rollout of J&J’s vaccine from its Janssen unit, the European Medicines Agency (EMA) said on Friday, adding that one person had died and that one case was reported in a clinical trial.

It was the first news of EMA’s probe of the J&J vaccine, while AstraZeneca’s coronavirus vaccine has been dogged for weeks over possible links to rare blood clots in the brain and abdomenJohn F. Kennedy, which the EMA has confirmedwhen intensive care was at capacity with just over 70 patients..

Copyright © 2011 JIN SHI